Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Nir, I.
1980.
Vol. 4,
Issue. ,
p.
204.
Lien, Eric J.
Lipsett, Lawrence R.
and
Lien, Linda L.
1983.
STRUCTURE SIDE-EFFECT SORTING OF DRUGS VI. OTOTOXICITIES.
Journal of Clinical Pharmacy and Therapeutics,
Vol. 8,
Issue. 1,
p.
15.
Gustafsson, LL
Walker, O
Alvan, G
Beermann, B
Estevez, F
Gleisner, L
Lindstrom, B
and
Sjoqvist, F
1983.
Disposition of chloroquine in man after single intravenous and oral doses..
British Journal of Clinical Pharmacology,
Vol. 15,
Issue. 4,
p.
471.
Iqbal, S. Md.
and
Srivatsav, C. B. P.
1984.
Cholarmphenicol ototoxicity.
The Journal of Laryngology & Otology,
Vol. 98,
Issue. 5,
p.
523.
Sykes, H.
1984.
The ototoxicity of chloroquine sulphate in the guinea pig.
British Journal of Audiology,
Vol. 18,
Issue. 2,
p.
59.
Davidson, J.
Hyde, M.L.
and
Alberti, P.W.
1989.
Epidemiologic patterns in childhood hearing loss: a review.
International Journal of Pediatric Otorhinolaryngology,
Vol. 17,
Issue. 3,
p.
239.
Walker, Ernest M.
Fazekas-May, Mary A.
and
Bowen, William R.
1990.
Nephrotoxic and Ototoxic Agents.
Clinics in Laboratory Medicine,
Vol. 10,
Issue. 2,
p.
323.
Cecatto, Suzana B.
Garcia, Roberta I. D.
Costa, Kátia S.
Anti, Sônia M. A.
Longone, Erika
and
Rapoport, Priscila B.
2004.
Perda auditiva sensorioneural no lúpus eritematoso sistêmico: relato de três casos.
Revista Brasileira de Otorrinolaringologia,
Vol. 70,
Issue. 3,
p.
398.
Prayuenyong, Pattarawadee
Kasbekar, Anand V.
and
Baguley, David M.
2020.
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
Frontiers in Public Health,
Vol. 8,
Issue. ,
Britto, Diana Babini Lapa de Albuquerque
Rocha, Mônyka Ferreira Borges
Silva, Jéssica Dayane da
Pinheiro, Natália dos Santos
Silva, Lidiane Kelvin da
and
Advíncula, Karina Paes
2021.
Auditive and Vestibular Changes Related to the Use of Hydroxychlorochine and Chlorochine: An Integrative Review
.
International Archives of Otorhinolaryngology,
Vol. 25,
Issue. 02,
p.
e309.
Little, Christine
and
Cosetti, Maura K.
2021.
A Narrative Review of Pharmacologic Treatments for COVID‐19: Safety Considerations and Ototoxicity.
The Laryngoscope,
Vol. 131,
Issue. 7,
p.
1626.
De Luca, Pietro
Scarpa, Alfonso
De Bonis, Egidio
Cavaliere, Matteo
Viola, Pasquale
Gioacchini, Federico Maria
Ralli, Massimo
Ettore, Cassandro
and
Claudia, Cassandro
2021.
Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
American Journal of Otolaryngology,
Vol. 42,
Issue. 5,
p.
102640.
Marin, Sergio
Martin Val, Alba
Bosch Peligero, Maite
Rodríguez-Bernuz, Cristina
Pérez-Ricart, Ariadna
Vilaró Jaques, Laia
Paredes, Roger
Roca, Josep
and
Quiñones, Carles
2022.
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Pharmaceuticals,
Vol. 15,
Issue. 5,
p.
634.
Fernandes, Carolina Pereira
Vernier, Luíza Silva
Dallegrave, Eliane
and
Machado, Márcia Salgado
2022.
The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review.
International Archives of Otorhinolaryngology,
Vol. 26,
Issue. 01,
p.
e167.